Focusing on drug versus disease mechanisms and on clinical subgrouping to advance personalised medicine in psychiatry

E-ISSN： 1601-5215|26|6|327-333

ISSN： 0924-2708

Source： Acta Neuropsychiatrica, Vol.26, Iss.6, 2013-06, pp. : 327-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalised medicine in psychiatry? Yes, but how?

Acta Neuropsychiatrica, Vol. 26, Iss. 6, 2014-11 ,pp. : 325-326

Cambridge University Press

Access to resources Recommend Favorite

Phencyclidine, excitatory amino acids, psychiatry and drug abuse: Historical perspectives on clinical-laboratory interactions

Acta Neuropsychiatrica, Vol. 9, Iss. 2, 1997-06 ,pp. : 87-88

Cambridge University Press

Access to resources Recommend Favorite

History of the Introduction of Lithium into Medicine and Psychiatry

Acta Neuropsychiatrica, Vol. 22, Iss. 3, 2010-06 ,pp. : 161-161

Cambridge University Press

Access to resources Recommend Favorite

Standard electroencephalography in clinical psychiatry: a practical handbook

Acta Neuropsychiatrica, Vol. 23, Iss. 5, 2011-10 ,pp. : 256-256

Cambridge University Press

Access to resources Recommend Favorite

Routine clinical outcomes measurement in old age psychiatry

International Psychogeriatrics, Vol. 21, Iss. 6, 2009-12 ,pp. : 990-995

Cambridge University Press

Access to resources Recommend Favorite